ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $214,777 | -17.2% | 10,306 | -4.8% | 0.15% | -10.1% |
Q2 2023 | $259,354 | +25.2% | 10,829 | -1.6% | 0.17% | +23.4% |
Q1 2023 | $207,170 | +18.2% | 11,008 | 0.0% | 0.14% | +11.4% |
Q4 2022 | $175,247 | -2.6% | 11,008 | 0.0% | 0.12% | -10.9% |
Q3 2022 | $180,000 | +16.1% | 11,008 | 0.0% | 0.14% | +21.1% |
Q2 2022 | $155,000 | -52.7% | 11,008 | -18.6% | 0.11% | -43.8% |
Q1 2022 | $328,000 | +20.1% | 13,516 | +15.8% | 0.20% | +18.0% |
Q4 2021 | $273,000 | +34.5% | 11,672 | -4.1% | 0.17% | +22.0% |
Q3 2021 | $203,000 | -31.2% | 12,172 | 0.0% | 0.14% | -9.6% |
Q2 2021 | $295,000 | -6.1% | 12,172 | 0.0% | 0.16% | -12.8% |
Q1 2021 | $314,000 | -51.8% | 12,172 | 0.0% | 0.18% | -57.1% |
Q4 2020 | $651,000 | -28.1% | 12,172 | -44.5% | 0.42% | -25.4% |
Q3 2020 | $905,000 | – | 21,921 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |